carboxycinnamic acid bishydroxamide

Known as: m-carboxycinnamic acid bishydroxamide, m-Carboxycinnamic Acid Bishydroxamic Acid, CBHA cpd 
A hybrid polar compound that induces terminal differentiation and/or apoptosis in various transformed cells. It is an inhibitor of histone… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2014
01219982014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Insufficient epigenetic reprogramming of donor nuclei is believed to be one of the most important causes of low development… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Tumor necrosis factor-(TNF-)-α upregulates plasminogen activator inhibitor-(PAI-) 1 expression in pleural mesothelial cells (PMCs… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Somatic cell nuclear transfer (SCNT) has shown tremendous potential for understanding the mechanisms of reprogramming and… (More)
Is this relevant?
2005
2005
In the present study, we aimed to elucidate the mechanism responsible for the interactive effects of histone deacetylase (HDAC… (More)
Is this relevant?
2000
2000
BACKGROUND Neuroblastoma is a common childhood cancer with a poor overall prognosis. Retinoic acids (RAs) have been studied as a… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Inhibitors of histone deacetylase (HDAC) have been shown to have both apoptotic and differentiating effects on various tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Hybrid polar compounds (HPCs) have been synthesized that induce terminal differentiation and/or apoptosis in various transformed… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?